Phathom Pharmaceuticals, Inc. (PHAT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Steven L. Basta M.B.A.
|
CEO, President & Director | 1.17M | -- | 1966 |
|
Mr. David A. Socks
|
Co-Founder | 28.33k | -- | 1975 |
|
Dr. Azmi Nabulsi M.D., M.P.H.
|
Co-Founder | 1.95M | -- | 1960 |
|
Mr. Sanjeev Narula
|
Chief Financial & Business Officer | 644.28k | -- | 1961 |
|
Ms. Anne Marie Cook Esq., J.D.
|
Chief Legal Officer & Corporate Secretary | 663.41k | -- | 1962 |
|
Mr. Jonathan Bentley
|
Senior VP and Head of Sales, Operations & Training | -- | -- | -- |
|
Mr. Robert Breedlove
|
VP of Finance & Principal Accounting Officer | -- | -- | -- |
|
Mr. Eric Sciorilli
|
Director of Business Development & Investor Relations | -- | -- | -- |
|
Mr. Bill Aprea J.D.
|
Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer | -- | -- | -- |
Phathom Pharmaceuticals, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 371
Description
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Corporate Governance
Upcoming Events
October 29, 2026 at 12:30 PM UTC
Phathom Pharmaceuticals, Inc. Earnings Date
